Migration and invasion ability of glioma cells was also decreased following BRG1 knockdown, assessed by cell migration and Matrigel invasion assay, largely through the downregulation of MMP-2 expression [63]. This evidence concerns the gene SMARCA4 and central nervous system cancer.